http://purl.org/np/RA76V4GyZmUmpcSMFnG_WPMV2sm6Q1vAtA_OTXzSvTVcc#Head http://purl.org/np/RA76V4GyZmUmpcSMFnG_WPMV2sm6Q1vAtA_OTXzSvTVcc http://www.nanopub.org/nschema#hasAssertion http://purl.org/np/RA76V4GyZmUmpcSMFnG_WPMV2sm6Q1vAtA_OTXzSvTVcc#assertion http://purl.org/np/RA76V4GyZmUmpcSMFnG_WPMV2sm6Q1vAtA_OTXzSvTVcc http://www.nanopub.org/nschema#hasProvenance http://purl.org/np/RA76V4GyZmUmpcSMFnG_WPMV2sm6Q1vAtA_OTXzSvTVcc#provenance http://purl.org/np/RA76V4GyZmUmpcSMFnG_WPMV2sm6Q1vAtA_OTXzSvTVcc http://www.nanopub.org/nschema#hasPublicationInfo http://purl.org/np/RA76V4GyZmUmpcSMFnG_WPMV2sm6Q1vAtA_OTXzSvTVcc#pubinfo http://purl.org/np/RA76V4GyZmUmpcSMFnG_WPMV2sm6Q1vAtA_OTXzSvTVcc http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://purl.org/np/RA76V4GyZmUmpcSMFnG_WPMV2sm6Q1vAtA_OTXzSvTVcc#assertion http://purl.obolibrary.org/obo/DOID_13884 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Disease http://purl.org/np/RA76V4GyZmUmpcSMFnG_WPMV2sm6Q1vAtA_OTXzSvTVcc#association http://www.w3.org/1999/02/22-rdf-syntax-ns#object http://purl.obolibrary.org/obo/DOID_13884 http://purl.org/np/RA76V4GyZmUmpcSMFnG_WPMV2sm6Q1vAtA_OTXzSvTVcc#association http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate https://w3id.org/biolink/vocab/treats http://purl.org/np/RA76V4GyZmUmpcSMFnG_WPMV2sm6Q1vAtA_OTXzSvTVcc#association http://www.w3.org/1999/02/22-rdf-syntax-ns#subject https://identifiers.org/drugbank:DB04861 http://purl.org/np/RA76V4GyZmUmpcSMFnG_WPMV2sm6Q1vAtA_OTXzSvTVcc#association http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement http://purl.org/np/RA76V4GyZmUmpcSMFnG_WPMV2sm6Q1vAtA_OTXzSvTVcc#association http://www.w3.org/2000/01/rdf-schema#label "Nebivolol Tablets are contraindicated in the following conditions: * Severe bradycardia * Heart block greater than first degree * Patients with cardiogenic shock * Decompensated cardiac failure * Sick sinus syndrome (unless a permanent pacemaker is in place) * Patients with severe hepatic impairment (Child-Pugh >B) * Patients who are hypersensitive to any component of this product * Severe bradycardia (4) * Heart block greater than first degree (4) * Patients with cardiogenic shock (4) * Decompensated cardiac failure (4) * Sick sinus syndrome (unless a permanent pacemaker is in place) (4) * Patients with severe hepatic impairment (Child-Pugh >B) (4) * Hypersensitive to any component of this product (4)" http://purl.org/np/RA76V4GyZmUmpcSMFnG_WPMV2sm6Q1vAtA_OTXzSvTVcc#association https://w3id.org/biolink/vocab/provided_by https://w3id.org/um/NeuroDKG http://purl.org/np/RA76V4GyZmUmpcSMFnG_WPMV2sm6Q1vAtA_OTXzSvTVcc#association https://w3id.org/biolink/vocab/relation https://schema.org/MedicalContraindication https://identifiers.org/drugbank:DB04861 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Drug http://purl.org/np/RA76V4GyZmUmpcSMFnG_WPMV2sm6Q1vAtA_OTXzSvTVcc#provenance http://purl.org/np/RA76V4GyZmUmpcSMFnG_WPMV2sm6Q1vAtA_OTXzSvTVcc#assertion http://www.w3.org/ns/prov#wasAttributedTo https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RA76V4GyZmUmpcSMFnG_WPMV2sm6Q1vAtA_OTXzSvTVcc#pubinfo http://purl.org/np/RA76V4GyZmUmpcSMFnG_WPMV2sm6Q1vAtA_OTXzSvTVcc#sig http://purl.org/nanopub/x/hasAlgorithm RSA http://purl.org/np/RA76V4GyZmUmpcSMFnG_WPMV2sm6Q1vAtA_OTXzSvTVcc#sig http://purl.org/nanopub/x/hasPublicKey MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB http://purl.org/np/RA76V4GyZmUmpcSMFnG_WPMV2sm6Q1vAtA_OTXzSvTVcc#sig http://purl.org/nanopub/x/hasSignature FMtsyGe/0Q76OGNTIVlFrDFqPsDSIPLli+mQmwALJL5IlP45AFVJt0JPK3Rc6FuiEtEiRs0efqglxAzDnoeEwjKX7xv67eIklwpNK4ymEcUGFoXj28jB1HoSAI/V7U/Yl9z8I8i1cS81jVZaawfE8wShiQg9e3oOpg+TZJk9QKQ= http://purl.org/np/RA76V4GyZmUmpcSMFnG_WPMV2sm6Q1vAtA_OTXzSvTVcc#sig http://purl.org/nanopub/x/hasSignatureTarget http://purl.org/np/RA76V4GyZmUmpcSMFnG_WPMV2sm6Q1vAtA_OTXzSvTVcc http://purl.org/np/RA76V4GyZmUmpcSMFnG_WPMV2sm6Q1vAtA_OTXzSvTVcc http://purl.org/dc/terms/created 2021-08-23T12:39:25.045+02:00 http://purl.org/np/RA76V4GyZmUmpcSMFnG_WPMV2sm6Q1vAtA_OTXzSvTVcc http://purl.org/dc/terms/creator https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RA76V4GyZmUmpcSMFnG_WPMV2sm6Q1vAtA_OTXzSvTVcc https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM http://purl.org/np/RA76V4GyZmUmpcSMFnG_WPMV2sm6Q1vAtA_OTXzSvTVcc https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM http://purl.org/np/RA76V4GyZmUmpcSMFnG_WPMV2sm6Q1vAtA_OTXzSvTVcc https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate http://purl.org/np/RAhNHZw6Urw_Mccs4qy6Ws3C9CRuaHpQx8AwuApbWkqnY